Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FreSH: NRT Sampling in Dental Practices
NCT05627596Phase 2Completed
- Start
- Jun 2023
- Primary completion
- Jun 2025
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of nicotine patch in Tobacco Use Disorder (TUD) (2 arms). Primary endpoint: 7-day Biochemically Confirmed Point Prevalence Abstinence at 6 months. Started Jun 2023; status: completed.
02
Drugs
nicotine patch
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT05627596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05627596.